{"id":55737,"date":"2024-10-15T09:21:29","date_gmt":"2024-10-15T09:21:29","guid":{"rendered":"https:\/?p=55737"},"modified":"2024-10-15T09:23:17","modified_gmt":"2024-10-15T09:23:17","slug":"unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/","title":{"rendered":"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast"},"content":{"rendered":"

UnitedHealth Group Incorporated (UNH) <\/a>is set to release its highly anticipated Q3 earnings report. Investors and market analysts are watching closely as the company\u2019s performance will likely set the tone for the managed care and healthcare services sectors for the remainder of the year. A key focal point is UnitedHealth\u2019s ability to meet expectations, particularly in light of recent industry-wide challenges, such as the hack at its subsidiary Change Healthcare earlier this year.<\/p>\n

Before we dive in, we have a special offer! For a limited time, you can get 70% off Stock Target Advisor\u2019s premium features. Claim your discount<\/a> here!<\/p>\n

\"Promotion<\/a><\/p>\n

Expected Q3 Earnings Report of UnitedHealth Group:<\/h2>\n

The consensus among analysts is that UnitedHealth Group will report earnings of $7 per share, driven by an estimated revenue of $99.1 billion for the third quarter of 2024. This marks a significant increase in both profit and revenue from the previous year, signaling potential growth despite hurdles faced earlier. One of the critical metrics to assess the company\u2019s performance is the medical cost ratio, which tracks the percentage of premiums paid out to cover healthcare expenses. Analysts expect this ratio to come in at 84.4%, a rise from the 82.3% reported in the same quarter last year.<\/p>\n

\"UNH-<\/a><\/p>\n

The company\u2019s performance this quarter is particularly critical as it follows an industry-wide cyberattack earlier this year, which disrupted operations and posed financial challenges. UnitedHealth stated in July that the hack would likely reduce its annual earnings by 60 to 70 cents per share due to the resulting operational disruption. Despite these headwinds, if UnitedHealth can meet or exceed these earnings projections, it may restore investor confidence and ease concerns in the healthcare sector.<\/p>\n

 <\/p>\n

Stock Target Advisor’s Analysis on UnitedHealth Group:<\/h2>\n

According to Stock Target Advisor<\/a>, the stock forecast for UnitedHealth Group stands at an average target price of USD 604.45 over the next 12 months, with the consensus rating being a strong buy. Their analysis presents a neutral outlook on the stock, balancing between seven positive and seven negative signals.<\/p>\n

Among the positives, UnitedHealth benefits from high market capitalization, superior risk-adjusted returns, and strong capital utilization. The company has also demonstrated positive cash flow and free cash flow in the recent four quarters, highlighting its operational efficiency. However, the stock does have some notable downsides. It is considered overpriced compared to its earnings, book value, and cash flow. Additionally, UnitedHealth is highly leveraged, which might raise concerns about its long-term financial stability.<\/p>\n

 <\/p>\n

Is now the time to buy UNH? Access our full analysis report here, it\u2019s free.<\/a><\/p>\n

Conclusion:<\/h2>\n

As UnitedHealth Group prepares to release its Q3 earnings report, investors are looking for reassurance that the company can maintain stability and growth amid challenges. With analysts forecasting strong results, particularly in revenue and profit, a report in line with these expectations could help calm concerns about the company’s financial health and the broader healthcare sector<\/p>\n","protected":false},"excerpt":{"rendered":"

UnitedHealth Group Incorporated (UNH) is set to release its highly anticipated Q3 earnings report. Investors and market analysts are watching closely as the company\u2019s performance…<\/p>\n","protected":false},"author":17,"featured_media":36435,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-55737","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nUnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast<\/title>\n<meta name=\"description\" content=\"UnitedHealth Group\u2019s Q3 earnings report could ease investor concerns with expected $7 EPS and 84.4% medical cost ratio. Explore the full analysis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast\" \/>\n<meta property=\"og:description\" content=\"UnitedHealth Group\u2019s Q3 earnings report could ease investor concerns with expected $7 EPS and 84.4% medical cost ratio. Explore the full analysis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-15T09:21:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-15T09:23:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/07\/STA-Banner-2-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Muzzammil Ahmad\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/x.com\/Muzzammil625\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Muzzammil Ahmad\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/\"},\"author\":{\"name\":\"Muzzammil Ahmad\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\"},\"headline\":\"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast\",\"datePublished\":\"2024-10-15T09:21:29+00:00\",\"dateModified\":\"2024-10-15T09:23:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/\"},\"wordCount\":487,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/\",\"name\":\"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2024-10-15T09:21:29+00:00\",\"dateModified\":\"2024-10-15T09:23:17+00:00\",\"description\":\"UnitedHealth Group\u2019s Q3 earnings report could ease investor concerns with expected $7 EPS and 84.4% medical cost ratio. Explore the full analysis.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\",\"name\":\"Muzzammil Ahmad\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"caption\":\"Muzzammil Ahmad\"},\"description\":\"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/\",\"https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625\"],\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast","description":"UnitedHealth Group\u2019s Q3 earnings report could ease investor concerns with expected $7 EPS and 84.4% medical cost ratio. Explore the full analysis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/","og_locale":"en_US","og_type":"article","og_title":"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast","og_description":"UnitedHealth Group\u2019s Q3 earnings report could ease investor concerns with expected $7 EPS and 84.4% medical cost ratio. Explore the full analysis.","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2024-10-15T09:21:29+00:00","article_modified_time":"2024-10-15T09:23:17+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/07\/STA-Banner-2-1.jpg","type":"image\/jpeg"}],"author":"Muzzammil Ahmad","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/x.com\/Muzzammil625","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"Muzzammil Ahmad","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/"},"author":{"name":"Muzzammil Ahmad","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8"},"headline":"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast","datePublished":"2024-10-15T09:21:29+00:00","dateModified":"2024-10-15T09:23:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/"},"wordCount":487,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/","name":"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2024-10-15T09:21:29+00:00","dateModified":"2024-10-15T09:23:17+00:00","description":"UnitedHealth Group\u2019s Q3 earnings report could ease investor concerns with expected $7 EPS and 84.4% medical cost ratio. Explore the full analysis.","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/unitedhealth-group-q3-2024-earnings-analysis-profit-and-revenue-forecast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"UnitedHealth Group Q3 2024 Earnings Analysis: Profit and Revenue Forecast"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8","name":"Muzzammil Ahmad","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","caption":"Muzzammil Ahmad"},"description":"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.","sameAs":["https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/","https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625"],"url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/55737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=55737"}],"version-history":[{"count":2,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/55737\/revisions"}],"predecessor-version":[{"id":55741,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/55737\/revisions\/55741"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/36435"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=55737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=55737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=55737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}